ID: ALA4282891

Max Phase: Preclinical

Molecular Formula: C22H20BrN3O3

Molecular Weight: 454.32

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=c1c2cc(-c3ccc(Br)cc3)n(-c3ccccc3)c2ncn1CCOCCO

Standard InChI:  InChI=1S/C22H20BrN3O3/c23-17-8-6-16(7-9-17)20-14-19-21(26(20)18-4-2-1-3-5-18)24-15-25(22(19)28)10-12-29-13-11-27/h1-9,14-15,27H,10-13H2

Standard InChI Key:  ZVUYOGCMZKVMGS-UHFFFAOYSA-N

Associated Targets(non-human)

unidentified influenza virus 265 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 454.32Molecular Weight (Monoisotopic): 453.0688AlogP: 3.63#Rotatable Bonds: 7
Polar Surface Area: 69.28Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 1.16CX LogP: 3.60CX LogD: 3.60
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.43Np Likeness Score: -1.14

References

1. Pathania S, Rawal RK..  (2018)  Pyrrolopyrimidines: An update on recent advancements in their medicinal attributes.,  157  [PMID:30114661] [10.1016/j.ejmech.2018.08.023]

Source